Skip to main content

ORIGINAL RESEARCH article

Front. Toxicol.
Sec. Computational Toxicology and Informatics
Volume 7 - 2025 | doi: 10.3389/ftox.2025.1518769

Comparing Computational Times for Simulations When Using PBPK Model Template and Stand-Alone Implementations of PBPK Models

Provisionally accepted
  • 1 United States Environmental Protection Agency (EPA), Washington, United States
  • 2 Oak Ridge Associated Universities, Oak Ridge, Tennessee, United States

The final, formatted version of the article will be published soon.

    We previously developed a PBPK model template that consists of a single model "superstructure" with equations and logic found in many physiologically based pharmacokinetic (PBPK) models. Using the template, one can implement PBPK models with different combinations of structures and features. To identify factors that influence computational time required for PBPK model simulations, we conducted timing experiments using various implementations of PBPK models for dichloromethane and chloroform, including template and stand-alone implementations, and simulating four different exposure scenarios. For each experiment, we measured the required computational time and evaluated the impacts of including various model features (e.g., number of output variables calculated) and incorporating various design choices (e.g., different methods for estimating blood concentrations). We observed that model implementations that treat body weight and dependent quantities as constant (fixed) parameters can result in a 30% time savings compared with options that treat body weight and dependent quantities as time-varying. We also observed that decreasing the number of state variables by 36% in our PBPK model template led to a decrease of 20-35% in computational time. Other factors, such as the number of output variables, the method for implementing conditional statements, and the method for estimating blood concentrations, did not have large impacts on simulation time. In general, simulations with PBPK model template implementations of models required more time than simulations with stand-alone implementations, but the flexibility and (human) time savings in preparing and reviewing a model implemented using the PBPK model template may justify the increases in computational time requirements. Our findings concerning how PBPK model design and implementation decisions impact computational speed can benefit anyone seeking to develop, improve, or apply a PBPK model, with or without the PBPK model template.

    Keywords: PBPK model, Template model, Risk Assessment, pharmacokinetics, computational timing

    Received: 28 Oct 2024; Accepted: 30 Jan 2025.

    Copyright: © 2025 Bernstein, Schlosser and Kapraun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Dustin F Kapraun, United States Environmental Protection Agency (EPA), Washington, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.